GGHC
RPTX

Gilder Gagnon Howe & Co’s Repare Therapeutics RPTX Stock Holding History

Gilder Gagnon Howe & Co’s Portfolio RPTX Stock Details RPTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-17
Closed – – 343
2021
Q4 		$0 Sell
17
-3,214
-99% -$75.7K ﹤0.01% 421
2021
Q3 		$85K Sell
3,231
-2
-0.1% -$65 ﹤0.01% 376
2021
Q2 		$101K Hold
3,233
– – ﹤0.01% 369
2021
Q1 		$99K Sell
3,233
-3
-0.1% -$102 ﹤0.01% 349
2020
Q4 		$111K Sell
3,236
-3
-0.1% -$90 ﹤0.01% 302
2020
Q3 		$100K Sell
3,239
-472
-13% -$12.5K ﹤0.01% 308
2020
Q2 		$115K Buy
+3,711
New +$119K ﹤0.01% 279

Other funds holding RPTX

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
CA
CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return

Gilder Gagnon Howe & Co's RPTX Position: Q1 2022 in Review

Gilder Gagnon Howe & Co sold out of Repare Therapeutics (RPTX) in Q1 2022, closing a stake of 17 shares.

Gilder Gagnon Howe & Co first reported a position in RPTX in Q2 2020 and held it in 7 quarters. The position peaked at $115K in Q2 2020. 62 funds tracked by Wall St. Rank hold RPTX as of Q1 2022.

  • Gilder Gagnon Howe & Co reported no remaining Repare Therapeutics position as of Q1 2022 after selling out during the quarter.
  • Gilder Gagnon Howe & Co sold 17 Repare Therapeutics shares in Q1 2022.
  • Gilder Gagnon Howe & Co first reported a position in Repare Therapeutics in Q2 2020 and held it in 7 quarters.
  • Gilder Gagnon Howe & Co's Repare Therapeutics position peaked at $115K in Q2 2020.
  • 62 funds tracked by Wall St. Rank held Repare Therapeutics as of Q1 2022.

Based on Gilder Gagnon Howe & Co's 13F filing for Q1 2022, filed 16 May 2022.